Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: Principles, approaches, and laboratory aspects

2003-06-01

Leukemia , Volume 17 - Issue 6 p. 1013- 1034

Additional Metadata
Keywords	Fusion genes, Immunoglobulin, Leukemia, Lymphoma, Minimal residual disease (MRD), Multiple myeloma, Real-time quantitative PCR (RQ-PCR), T-cell receptor
Persistent URL	doi.org/10.1038/sj.leu.2402922, hdl.handle.net/1765/68758
Journal	Leukemia
Organisation	Department of Immunology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	van der Velden, V., Hochhaus, A., Cazzaniga, G., Szczepanski, T., Gabert, J., & van Dongen, J. (2003). Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: Principles, approaches, and laboratory aspects. Leukemia (Vol. 17, pp. 1013–1034). doi:10.1038/sj.leu.2402922

Publication